Kesler Norman & Wride LLC Raises Stake in CorVel Co. (NASDAQ:CRVL)

Kesler Norman & Wride LLC increased its position in shares of CorVel Co. (NASDAQ:CRVL) by 295.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,904 shares of the business services provider’s stock after acquiring an additional 5,158 shares during the period. Kesler Norman & Wride LLC’s holdings in CorVel were worth $769,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of CRVL. Point72 DIFC Ltd bought a new position in shares of CorVel in the 3rd quarter worth $88,000. Fifth Third Bancorp raised its position in CorVel by 45.9% during the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 101 shares in the last quarter. Jones Financial Companies Lllp purchased a new stake in CorVel during the fourth quarter valued at about $37,000. US Bancorp DE boosted its holdings in shares of CorVel by 225.4% in the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after purchasing an additional 266 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of CorVel by 175.2% in the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock worth $48,000 after purchasing an additional 275 shares in the last quarter. 51.36% of the stock is owned by institutional investors.

CorVel Stock Performance

Shares of CorVel stock opened at $111.50 on Thursday. CorVel Co. has a 52-week low of $76.20 and a 52-week high of $128.61. The company has a fifty day moving average of $112.42 and a 200-day moving average of $114.73. The stock has a market capitalization of $5.73 billion, a price-to-earnings ratio of 65.59 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded CorVel from a “buy” rating to a “hold” rating in a research report on Thursday, March 13th.

Insiders Place Their Bets

In other CorVel news, Director Steven J. Hamerslag sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the transaction, the director now owns 314,000 shares in the company, valued at approximately $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brandon O’brien sold 1,523 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the sale, the chief financial officer now owns 17,142 shares of the company’s stock, valued at approximately $2,049,497.52. This represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,200 shares of company stock valued at $3,824,115 in the last ninety days. Company insiders own 47.57% of the company’s stock.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.